shubham solanki

Financial Analyst.📈 📍Pune. Building Wealth One Model at a time

[shubham solanki @shubsoll]

@OlaElectric @bhash

Good Morning OLA Electric 

Order Id OET-727440310160821-AZO438
Scooter Reservation done on 16th Aug 2021
Scooter Colour Reserved MIDNIGHT BLUE
Advance Amount Paid 16th Sept 2021
Balance Payment Paid on 22nd Jan 2022

[jeevan patwa @jeevanpatwa]

Mixed day

#AxisCades bad results. As I keep telling, it is undergoing big transformation. Couple of quarters needed for things to stabilize. Have trust in the business and the management.

Silver lining
- ESAI doing well with 30% EBIDTA
- Aerospace acquisition looks interesting with 22% EBIDTA

#ManoramaInd blockbuster nos. Highest ever sales and PAT. Available at inexpensive valuations of 20x FY28 PE with 5x PAT growth visibility in 5 yrs

Disc. Sahasrar capital private limited, PMS - SEBI REGN No INP000007386. We are invested.

[jeevan patwa @jeevanpatwa]

#Lauruslab

Business is coming and investors too

[shubham solanki @shubsoll]

@sunilgurjar01 Laurus Labs
Xpro India
Kilburn Engineering
Scoda Tubes
SG Mart

[Yash Mehta @YMehta_]

Nifty 5 years CAGR is 8.8%
Nifty 10 years CAGR is 9.2%
Nifty 15 years CAGR is 9.3%
Nifty 20 years CAGR is 9.8%

Where is 12% CAGR as stated by FINFLUENCERS?

[jeevan patwa @jeevanpatwa]

Time to load up quality smallcaps. I see many small caps giving 5x-10x returns in next 5 yrs.

Reason

- part of wealth created by gold and silver rally will go into consumption and capital markets. India holds $5 trillion worth of gold

- Trade deal with Europe will create lot of mfg capacities and employment in India, though it takes 2-3 yrs

- valuation has become attractive in certain quality names

[ishmohit @ishmohit1]

There are market leaders available at 20x PE in today's market..It was tough to find them 1 year back. Selective opportunities available

[Vijay Kedia @VijayKedia1]

"Tera nifty all time high, phir bhi mera share aadha."
Same song, same story. Index near ATH… my stocks still at 50%. And the melody continues...🥳🥳

[Antifragile Thinking @unseenvalue]

When portfolio is down 50% the best stock to buy fresh is the one you already own and know better than an average person.

[jeevan patwa @jeevanpatwa]

#Lauruslab my hypothesis presented today at Alpha ideas

Transformed itself from ARV leader to fastest growing CDMO- 50% CAGR for CDMO FY25-28

FY28 nos will match with Divis FY26 nos. Similar top line 11000 crs with similar EBIDTA 32-33% and similar contribution from CDMO(50%). In fact, it has wider canvas (Bio, CGT, ADC) to play than Divis.

Will it have mcap then similar to Divis now?

[jeevan patwa @jeevanpatwa]

#Lauruslab bumper results- 60% gross margins, 26% EBIDTA

Capacities are created, capabilities are built, business is coming…

I estimate H2 to be very very good

[Vinay Vijay Nagori @vinaynagori5]

Kilburn engineering becomes 6x for me today.

Prime example of bolt on acquisition strategy done rightly. Numbers and execution by promoters was outstanding.

Intent for wealth creation, moat in business and sectoral tailwinds.
Still a long way to go I feel.

[jeevan patwa @jeevanpatwa]

#lauruslabs

While analysts were busy giving targets of 250 and 300, Laurus quietly delivered 100% returns in last 12 months

Surprising institutional investors increased stake by almost 5% in last 9 qtrs - acting against institutional recommendations

[Ian Cassel @iancassel]

Stocks rarely perform in the time frames we predict, and it’s why the market only works for investors that have a little more patience than we think we need.

[Dr. Rajeshwari Iyer @RajeshwariRW]

AIIMS Cut- off 2025

General Rank - 46
Result - Rejected

ST Rank - 223875
Result - Selected

Reservation in healthcare system completely insane.

Choose your Doctor wisely after all it's matter of life or death.

[Bharath @Quest_for_value]

Even though Laurus is highly tracked stock , i still feel that it is less understood by many.

It is highly polarized stock, ppl either love it or hate it but cannot ignore it... :)

Below is My take on #Lauruslabs Q4FY25 results

A Thread 🧵

[jeevan patwa @jeevanpatwa]

#Lauruslabs good results

CDMO and CMO to drive growth for FY26 and beyond

CDMO grew 50%. Laurus becomes second largest listed Indian CDMO after Divis with 1500 cr revenue, including small and large molecule.

I expect CDMO to grow at 50% CAGR for next 2 yrs with few large molecules in pipeline.

FDF will see 10-12% growth and API to remain flat.

Overall I expect 20% sales growth for FY26 (6700 crs) and 24% EBIDTA.

Spending 250 cr for biologics facility in Vizag. Animal health facility is ready. All the validations should happen in FY26. Agrochemicals commissioned in Q4. Gene therapy and viral vector facility will be ready by Mar’26. Cell therapy expansion will be done by Sep’25.

KRKA CMO contract will start from Q3.

[Gaurav Munjal @gauravmunjal]

Let’s ban Game of Thrones, Succession, Sacred Games, Black Warrant and other Shows like these as well while we are at it. They are also available for access easily behind a Paywall.

[jeevan patwa @jeevanpatwa]

#Lauruslab results below expectations. 5% Gross margin improvement qoq and yoy is positive surprise.

Few CMO and CDMO deliveries to start from H2.

My view remains unchanged - capacities are created, capabilities are built - business will come

[Intrinsic Compounding @soicfinance]

"I didn't intend to get Rich, I wanted to get Independent. I just overshot!"

Excellent life advice from Charlie Munger 👑

Credit- A clip taken from Mr. Munger's interview uploaded on Ross School Of Business YouTube channel

[Vinay Vijay Nagori @vinaynagori5]

Kilburn engg bags huge orders. Expecting bumper FY25. Expecting the management to outperform their guidance here.